|
|
|
Basel,
20 October 2006
For the fifth consecutive year, Roche was named to Science’s
list of Top 20 Employers in the Biotech and Pharmaceutical
Industry, moving up in rank for the fourth straight year
to number three on the list, selected from more than 330
companies. Genentech, also a member of the Roche Group
was again ranked number one.
Roche
was singled out in three areas: being an innovative leader
in the industry, having work culture values that are aligned
with personal values and having a clear vision of where
it is headed.
|
|
Researcher
on a mircroscope
|
|
|
|
|
|
|
“At Roche, our success is based on scientific innovation.
Talented people working together are the major factor in that
success,” said Jonathan Knowles, member of the Roche Corporate
Executive Committee and Head of Global Research. “The exciting
scientific environment we have created, the unique way in which
we share knowledge within the company and with our partners in
our innovation network, as well as how we develop people helps
us to attract new talent and retain the talented people we have,”
added Knowles.
“We are
very proud of the recent Science recognition and other workplace
honors that validate our commitment to being an employer of choice,”
said Gottlieb Keller, member of the Roche Corporate Executive
Committee and head Corporate Services and Human Resources.
The Top 20
list was the result of a month-long online survey by Science of
readers, subscribers and others working in the biotech and pharmaceutical
industry. Participants rated 330 companies on 42 different attributes
from seven different categories: corporate image, leadership and
direction, financial prowess, work culture/environment, work/life
balance, academics and collegial exchange, and compensation and
benefits
About Roche
Headquartered in Basel, Switzerland, Roche is one of the world’s
leading research-focused healthcare groups in the fields of pharmaceuticals
and diagnostics. As a supplier of innovative products and services
for the early detection, prevention, diagnosis and treatment of
disease, the Group contributes on a broad range of fronts to improving
people’s health and quality of life. Roche is a world leader
in diagnostics, the leading supplier of medicines for cancer and
transplantation and a market leader in virology. In 2005 sales
by the Pharmaceuticals Division totalled 27.3 billion Swiss francs,
and the Diagnostics Division posted sales of 8.2 billion Swiss
francs. Roche employs roughly 70,000 people in 150 countries and
has R&D agreements and strategic alliances with numerous partners,
including majority ownership interests in Genentech and Chugai.
Additional information about the Roche Group is available on the
Internet (www.roche.com).
All trademarks
used or mentioned in this release are protected by law.
Additional
information
- Survey
|
|
